Home › Phila. biotech firm to defer executive bonuses
 

Keywords :   


Phila. biotech firm to defer executive bonuses

2015-08-31 20:45:14| Biotech - Topix.net

Hemispherx Biopharma said Monday it is deferring all executive bonus payments until the Philadelphia biotechnology company achieves manufacturing goals at it newly renovated plant in North Jersey. According to documents filed with the Securities and Exchange Commission, the employment contracts for both Carter and Equels include the opportunity this year to earn bonuses of up to 25 percent of their base salary.

Tags: firm executive biotech bonuses

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.06Potential Tropical Cyclone One Graphics
17.06Potential Tropical Cyclone One Forecast Discussion Number 1
17.06Potential Tropical Cyclone One Wind Speed Probabilities Number 1
17.06Potential Tropical Cyclone One Public Advisory Number 1
17.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
17.06Potential Tropical Cyclone One Forecast Advisory Number 1
17.06New Federal Government Filing Requirement Regarding Ownership of LLCs and Corporations
17.06Manufacturers Reps That Sell to International Customers June 26 Networking Event
More »